A lymphoma diagnosis looks different at 17 than it does at 55, and this resource is built around that reality. It covers the unique physical, emotional, and practical challenges that adolescents and young adults (ages 15 to 39) face: from fertility and body image concerns to school, work, and health insurance. It also points to programs and resources designed specifically to support AYAs through diagnosis and beyond.
If your treatment plan includes a biologic therapy, you may also have the option of a biosimilar: a closely related alternative that works the same way. This guide explains what biosimilars are, how the FDA reviews and approves them, and which ones are currently available for lymphoma patients. It also includes a list of questions to bring to your care team when weighing your options.
Hodgkin lymphoma accounts for about 10% of all lymphomas in the United States and is most commonly diagnosed in young adults, though it can occur at any age. This resource covers the two main types, classical Hodgkin lymphoma and nodular lymphocyte-predominant Hodgkin lymphoma, along with how each is diagnosed, staged, and treated from initial therapy through relapsed or refractory disease. It also includes guidance on self-advocacy, therapies currently under investigation, and questions to bring to your healthcare team.
